Abstract:BACKGROUND: Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer worldwide. Until now, the molecular mechanisms underlying LUAD progression have not been fully explained. This study aimed to construct a competing endogenous RNA (ceRNA) network to predict the progression in LUAD. METHODS: Differentially expressed lncRNAs (DELs), miRNAs (DEMs), and mRNAs (DEGs) were identified from The Cancer Genome Atlas (TCGA) database with a vertical bar log(2)FC vertical bar > 1.0 and a false discovery rate (FDR) < 0.05. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), protein-protein interaction (PPI) network, and survival analyses were performed to analyse these DEGs involved in the ceRNA network. Subsequently, the drug-gene interaction database (DGIdb) was utilized to select candidate LUAD drugs interacting with significant DEGs. Then, lasso-penalized Cox regression and multivariate Cox regression models were used to construct the risk score system. Finally, based on the correlations between DELs and DEGs involved in the risk score system, the final ceRNA network was identified. Meanwhile, the GEPIA2 database and immunohistochemical (IHC) results were utilized to validate the expression levels of selected DEGs. RESULTS: A total of 340 DELs, 29 DEMs, and 218 DEGs were selected to construct the initial ceRNA network. Functional enrichment analyses indicated that 218 DEGs were associated with the KEGG pathway terms "microRNAs in cancer", "pathways in cancer", "cell cycle", "HTLV-1 infection", and the "PI3K-Akt signalling pathway". K-M survival analysis of all differentially expressed genes involved in the ceRNA network identified 24 DELs, 4 DEMs, and 29 DEGs, all of which were significantly correlated with LUAD progression (P < 0.05). Furthermore, 15 LUAD drugs interacting with 29 significant DEGs were selected. After lasso-penalized Cox regression and multivariate Cox regression modelling, PRKCE, DLC1, LATS2, and DPY19L1 were incorporated into the risk score system, and the results suggested that LUAD patients who had the high-risk score always suffered from a poorer overall survival. Additionally, the correlation coefficients between these 4 DEGs and their corresponding DELs involved in the ceRNA network suggested that there were 2 significant DEL-DEG pairs, NAV2-AS2 - PRKCE ( r = 0.430, P < 0.001) and NAV2-AS2 - LATS2 ( r = 0.338, P < 0.001). And NAV2-AS2 - mir-31 - PRKCE and NAV2-SA2 - mir-31 - LATS2 were finally identified as ceRNA network involved in the progression of LUAD. CONCLUSIONS: The lncRNA-miRNA-mRNA ceRNA network plays an essential role in predicting the progression of LUAD. These results may improve our understanding and provide novel mechanistic insights to explore prognosis and therapeutic drugs for LUAD patients.

Detection of Dysregulated Competing Endogenous RNA Modules Associated with Clear Cell Kidney Carcinoma.

Comprehensive Analysis of Lncrna Biomarkers in Kidney Renal Clear Cell Carcinoma by Lncrna-Mediated Cerna Network.

Identification Of Rna Transcript Makers Associated With Prognosis Of Kidney Renal Clear Cell Carcinoma By A Competing Endogenous Rna Network Analysis

Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma

Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma

Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic Signature in Kidney Renal Papillary Cell Carcinoma

Integrated analysis of lncRNA associated-competing endogenous RNAs as prognostic biomarkers in clear cell renal carcinoma.

Construction and Comprehensive Analysis of Dysregulated Long Non-Coding RNA-associated Competing Endogenous RNA Network in Clear Cell Renal Cell Carcinoma

Construction and Analysis of lncRNA-miRNA-mRNA ceRNA Network Identify an Eight-Gene Signature as a Potential Prognostic Factor in Kidney Renal Papillary Cell Carcinoma (KIRP)

Identification of a three-long noncoding RNA prognostic model involved competitive endogenous RNA in kidney renal clear cell carcinoma

Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma

Identification of Six Potentially Long Noncoding RNAs As Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma

Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis

Competing Endogenous RNA Network Analysis Reveals Pivotal Cernas in Bladder Urothelial Carcinoma

A Cerna Network Composed of Survival-Related Lncrnas, Mirnas, and Mrnas in Clear Cell Renal Carcinoma.

Cuproptosis-related LINC01711 promotes the progression of kidney renal clear cell carcinoma

Prognostic signatures for renal cancer as identified by long non-coding and miRNA competing endogenous network analysis.

Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma

Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.

A prognostic nomogram based on competing endogenous RNA network for clear-cell renal cell carcinoma

Identification of NK cell inhibitory ligand CLEC2D-associating immune infiltration landscape and prognostic value in kidney renal clear cell carcinoma